Sarcopenia and Juvenile Idiopathic Arthritis
This study focuses on understanding muscle weakness and loss, known as sarcopenia, in teenagers and young adults living with Juvenile Idiopathic Arthritis (JIA). JIA is a long-lasting type of arthritis that starts in childhood. While we know sarcopenia can affect adults with similar conditions, it hasn't been well-studied in people with JIA. The researchers will screen patients aged 15 to 40 in France. They'll use simple tests like questionnaires, a handgrip strength test, and a special body scan called DEXA to measure muscles and body fat. They also want to understand how sarcopenia might affect daily life and overall well-being. The findings could help doctors better identify those at risk and provide earlier support, focusing on managing JIA, encouraging physical activity, and good nutrition.
En un coup d'œil
De quoi parle cette étude ?
This study wants to learn more about a condition called sarcopenia in people who have Juvenile Idiopathic Arthritis (JIA). JIA is a long-term type of arthritis that starts in childhood, causing joint pain and swelling. Sarcopenia means losing muscle strength and muscle mass. While we know this can happen in adults with inflammatory diseases, it’s not really been looked at closely in people with JIA.
The main goal of this study is to find out how common sarcopenia is among teenagers and young adults (aged 15 to 40) with JIA in France. The researchers also want to identify what might be linked to sarcopenia and how it affects people's daily lives and overall quality of life. They will gather information through questionnaires about diet, tiredness, and activity, measure handgrip strength, and use a special body scan called DEXA to check muscle and fat levels. They will also look at medical records.
By understanding more about sarcopenia in JIA, the study hopes to help doctors in the future. The findings could make it easier to spot patients who might be at risk of sarcopenia earlier. This could then lead to better and earlier support, focusing on managing their JIA, keeping active, and eating well. Ultimately, this could help people with JIA live better and healthier lives.
Points clés
- The study investigates muscle loss (sarcopenia) in young people and adults with JIA.
- It aims to understand how common sarcopenia is and what factors are linked to it.
- Participation involves questionnaires, a handgrip test, and a body scan (DEXA).
- Results could help doctors better identify and support JIA patients at risk in the future.
- It's a single visit assessment during routine care, with no new medicines for the study.
Qui peut être éligible ?
To be part of this study, you need to be between 15 and 40 years old and have been diagnosed with Juvenile Idiopathic Arthritis (JIA). You must be receiving care at one of the participating hospitals in France and be covered by the French social security system (which handles healthcare costs). Most importantly, you and, if you are under 18, your parents or legal guardians, must agree to take part and sign a consent form.
There are some reasons why someone might not be able to join. For example, if you are under legal guardianship, not covered by social security, are pregnant, or if you wouldn't be able to do some of the simple tests required, like the handgrip strength test or the special body scan (DEXA). Also, if you find it difficult to understand questionnaires, you might not be suitable for this study.
Cet étude pourrait-elle vous convenir ?
Répondez à ces questions rapides pour voir si vous êtes éligible. Ceci est un guide uniquement — l'équipe de recherche prend la décision finale.
- Are you between 15 and 40 years old?
- Have you been diagnosed with Juvenile Idiopathic Arthritis (JIA)?
- Are you a patient at a French hospital taking part in this study?
- Are you covered by French social security?
- Are you able to do a handgrip strength test and a DEXA scan?
En quoi consiste la participation ?
If you decide to take part in this study, you'll have a special assessment during one of your regular rheumatology appointments. First, you'll get detailed information about the study, and if you agree, you'll sign a consent form (if you're under 18, your parents or guardians will too). During this single visit, you will have your handgrip strength measured using a special device. You'll also have a body scan called a DEXA to check your muscle and fat levels. Finally, you'll fill out some questionnaires about your diet, how tired you feel, how active you are, and how your JIA affects your daily life. The study will also collect some information from your medical records, like your JIA history and treatments. These assessments are all part of a single visit and there's no medication involved or long-term follow-up specifically for the study. If the study identifies sarcopenia, your doctor might suggest additional care as part of your usual treatment.
Risques et avantages potentiels
Emplacements (1)
- Marie MullerCode postal vérifiéReims, France
Questions fréquentes
What is Juvenile Idiopathic Arthritis (JIA)?
JIA is a type of arthritis that appears in childhood, causing joint pain, swelling, and stiffness that can last a long time.
Qu'est-ce que la sarcopénie ?
Sarcopenia means having less muscle strength and muscle mass. It can make everyday activities harder.
Qu'est-ce qu'un examen DEXA ?
A DEXA scan is a quick, low-dose X-ray that measures bone density, but in this study, it's used to measure muscle and fat in your body.
Devrai-je prendre de nouveaux médicaments ?
No, this study does not involve taking any new medicines. It focuses on assessments and gathering information.
Combien de temps durera ma participation ?
Your participation will involve a single set of assessments during one of your regular hospital visits.
Comment en savoir plus
Ambre HITTINGER-ROUX
Parlez toujours à votre médecin généraliste ou spécialiste avant de décider de participer à une étude.
Intéressé à participer ?
Discussion
Discussion communautaire
Propulsé par notre forum à community.patient.info. Veuillez être respectueux — ceci n'est pas un avis médical.